Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
glutamine
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Phase:
Phase IV
Type:
Supportive care
Status:
Active
Age:
18 to 85
Sponsor:
Other
Protocol IDs:
GLU_07
, NCT00772824
2.
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
0309006308
, NCT00195013
3.
Efficacy of an Oral Formula in Prevention of Anti-Cancer Therapy Side Effects
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
06.23.CLI
, NCT00455247
4.
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
GI-05-0024
, NCT00255229
5.
Phase II Randomized Pilot Study of Glutamine for Vincristine-Induced Neuropathy in Pediatric Patients With Lymphoma, Leukemia, or Solid Tumors
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
5 to 21
Sponsor:
Other
Protocol IDs:
CPMC-AAAA6806
, CPMC-ICCR-3349, NCT00365768
6.
Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients
Phase:
No phase specified
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
EC1432-00
, HARECCTR0500034, NCT00563498
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute